GlassScriptPhysician profile
Jonathan J Sexton
NPI 1962723809
$1,077.48
in general payments reported to CMS, 2019-2025
9 companies · $68.65 in 2025
The $68.65 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $310 · 2020: $254 · 2023: $306 · 2024: $139 · 2025: $68.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $331 · Travel and Lodging: $147 · Consulting Fee: $35.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $331.26 |
| Travel and Lodging | $147.14 |
| Consulting Fee | $35.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $361.01 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $339.69 | 2023-2025 | Gore Tag Thoracic Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo |
| Bard Peripheral Vascular, INC. | $127.15 | 2019 | |
| Silk Road Medical, INC. | $115.00 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Shockwave Medical, INC | $50.50 | 2020 | |
| Medtronic, INC. | $35.00 | 2025 | |
| Polynovo North America LLC | $23.71 | 2024 | Novosorb Btm |
| Terumo Medical Corporation | $14.07 | 2019 | |
| Medtronic Vascular, INC. | $11.35 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Sexton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.